Tim Anderson Analyst PerformanceManaging Director, Senior Equity Research Analyst at Bank of AmericaTim Anderson is a stock analyst at Bank of America in the medical sector, covering 13 publicly traded companies. Over the past year, Tim Anderson has issued 20 stock ratings, including buy, hold, and sell recommendations. While full access to Tim Anderson's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Tim Anderson's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings25 Last 10 YearsBuy Recommendations52.00% 13 Buy RatingsCompanies Covered13 Unique Companies Ratings Distribution25RatingsDistribution of strong buy, buy, hold, and sell ratings by Tim Anderson.RatingPercentageCount Strong Buy0.0%0 ratings Buy52.0%13 ratings Hold28.0%7 ratings Sell20.0%5 ratingsOut of 25 total stock ratings issued by Tim Anderson at Bank of America, the majority (52.0%) have been Buy recommendations, followed by 28.0% Hold and 20.0% Sell.Best & Worst CallsBest Call00.0%PFESep 2016Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%PFEAug 2016Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ53.8% of companies on NASDAQ7 companiesNYSE46.2% of companies on NYSE6 companiesTim Anderson, an analyst at Bank of America, currently covers 13 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical13 companies100.0%Tim Anderson of Bank of America specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE8 companies61.5%LARGE CAP PHARMA5 companies38.5% About Tim AndersonTim Anderson currently works at BofA Securities, Inc., as Research Analyst from 2024. Dr. Anderson also formerly worked at Sanford C. Bernstein & Co. LLC, as Managing Director from 2007 to 2018, Wolfe Research LLC, as Managing Director & Senior Analyst from 2018 to 2024, Prudential Securities, as Research Analyst in 2003, Prudential Equity Group LLC, as Research Analyst from 2004 to 2007, and Harvard Medical School, as Emergency Medicine Resident in 1998. Dr. Anderson received his Masters Business Admin degree in 1996 and doctorate degree in 1996 from The University of Chicago and undergraduate degree in 1991 from the University of California.Follow on LinkedIn Tim Anderson's Ratings History at Bank of America Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsMTSRMetsera8/28/2025Boost Price Target$36.38$50.00Buy$0.0000.00% ROIAARDAardvark Therapeutics8/28/2025Lower Price Target$8.64$25.00Buy$0.0000.00% ROIAPGEApogee Therapeutics8/28/2025Boost Price Target$36.98$87.00Buy$0.0000.00% ROIPFEPfizer8/6/2025Boost Price Target$24.69$28.00Neutral$0.0000.00% ROIAMGNAmgen7/23/2025Boost Price Target$307.42$261.00Underperform$0.0000.00% ROIJNJJohnson & Johnson7/17/2025Boost Price Target$164.78$175.00Neutral$0.0000.00% ROIREGNRegeneron Pharmaceuticals4/17/2025Lower Price Target$549.28$547.00Underperform$0.0000.00% ROIJNJJohnson & Johnson4/10/2025Lower Price Target$149.02$159.00Neutral$0.0000.00% ROIAARDAardvark Therapeutics3/27/2025Boost Price Target$10.38$26.00Buy$0.0000.00% ROIAARDAardvark Therapeutics3/10/2025Initiated Coverage$10.13$22.00Buy$0.0000.00% ROIJNJJohnson & Johnson3/5/2025Boost Price Target$164.67$171.00Neutral$0.0000.00% ROIGILDGilead Sciences3/5/2025Boost Price Target$115.60$126.00Buy$0.0000.00% ROIAMGNAmgen3/5/2025Boost Price Target$315.78$294.00Underperform$0.0000.00% ROIABBVAbbVie3/4/2025Boost Price Target$213.05$223.00Neutral$0.0000.00% ROIMTSRMetsera2/25/2025Initiated Coverage$29.81$38.00Buy$0.0000.00% ROIMRNAModerna2/11/2025Lower Price Target$31.87$34.00Underperform$0.0000.00% ROIAMGNAmgen2/6/2025Boost Price Target$307.81$275.00Underperform$0.0000.00% ROIMRKMerck & Co., Inc.2/5/2025Lower Price Target$88.67$112.00Buy$0.0000.00% ROIJNJJohnson & Johnson1/23/2025Lower Price Target$145.39$159.00Neutral$0.0000.00% ROIJNJJohnson & Johnson1/17/2025Lower Price Target$147.26$160.00Neutral$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
